Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Cash from Operations: 2013-2024

Historic Cash from Operations for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to $300.1 million.

  • Surgery Partners' Cash from Operations rose 2822.09% to $83.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $176.9 million, marking a year-over-year decrease of 2288.58%. This contributed to the annual value of $300.1 million for FY2024, which is 214.43% up from last year.
  • Surgery Partners' Cash from Operations amounted to $300.1 million in FY2024, which was up 214.43% from $293.8 million recorded in FY2023.
  • In the past 5 years, Surgery Partners' Cash from Operations ranged from a high of $300.1 million in FY2024 and a low of $87.1 million during FY2021
  • In the last 5 years, Surgery Partners' Cash from Operations had a median value of $246.9 million in 2020 and averaged $217.3 million.
  • Per our database at Business Quant, Surgery Partners' Cash from Operations surged by 9065.64% in 2020 and then crashed by 6472.26% in 2021.
  • Surgery Partners' Cash from Operations (Annual) stood at $246.9 million in 2020, then crashed by 64.72% to $87.1 million in 2021, then skyrocketed by 82.32% to $158.8 million in 2022, then skyrocketed by 85.01% to $293.8 million in 2023, then increased by 2.14% to $300.1 million in 2024.
  • Its last three reported values are $300.1 million in FY2024, $293.8 million for FY2023, and $158.8 million during FY2022.